[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors

[1]  M. Millan,et al.  Novel Benzopyrano[3,4‐c]pyrrole Derivatives as Potent and Selective Dopamine D3 Receptor Antagonists. , 1999 .

[2]  M. Millan,et al.  Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. , 1999, Molecular pharmacology.

[3]  M. Millan,et al.  G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. , 1999, Molecular pharmacology.

[4]  M. Millan,et al.  A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. , 1998, The Journal of pharmacology and experimental therapeutics.

[5]  G. N. Bancroft,et al.  Binding of [3H]PD 128907, a Putatively Selective Ligand for the D3 Dopamine Receptor, in Rat Brain: A Receptor Binding and Quantitative Autoradiographic Study , 1998, Neuropsychopharmacology.

[6]  B. Levant.  The D3 dopamine receptor: neurobiology and potential clinical relevance. , 1997, Pharmacological reviews.

[7]  M. P. Turpin,et al.  Novel 6-substituted 2-aminotetralins with potent and selective affinity for the dopamine D3 receptor , 1996 .

[8]  M. Millan,et al.  [3H](+)S 14297: A novel, selective radioligand at cloned human dopamine D3 receptors , 1995, Neuropharmacology.

[9]  C Dacquet,et al.  Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. , 1995, The Journal of pharmacology and experimental therapeutics.

[10]  D. Gehlert,et al.  [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain. , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  P. Sokoloff,et al.  Novel dopamine receptors half a decade later. , 1995, Trends in pharmacological sciences.

[12]  M. Martres,et al.  Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.

[13]  R. Todd,et al.  Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. , 1994, The Journal of pharmacology and experimental therapeutics.